Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

BTAIBTAI
20 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in BIOXCEL THERAPEUTICS INC

CITADEL ADVISORS LLC holds 149,220 shares of BTAI (BIOXCEL THERAPEUTICS INC), worth $210,400 as of 2026-Q2. This is a new position.

Current Value

$210,400

Current Shares

149,220

Total Value Change

-$16.4M

Total Shares Change

-164,742

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
149,220
-
$210,4000.0%$1.41
35
2025-Q3
Exited
0
-100.0%
$00.0%$2.62
0
2025-Q2
New
11,378
-
$20,5940.0%$1.77
29
2024-Q2
Exited
0
-100.0%
$00.0%$20.48
0
2024-Q1
Increased
40,643
+662.5%
$114,6130.0%$45.12
24
2023-Q4
Decreased
5,330
-62.7%
$15,7240.0%$47.20
0
2023-Q3
Decreased
14,300
-1.6%
$36,1790.0%$40.48
0
2023-Q2
Decreased
14,529
-82.8%
$96,7630.0%$102.24
0
2023-Q1
Increased
84,432
+81.1%
$1.6M0.0%$297.60
39
2022-Q4
Decreased
46,611
-18.4%
$1M0.0%$343.68
0
2022-Q3
Increased
57,094
+29.9%
$675,0000.0%$181.44
31
2022-Q2
Decreased
43,957
-7.9%
$581,0000.0%$214.08
0
2022-Q1
Decreased
47,713
-0.2%
$997,0000.0%$347.04
0
2021-Q4
Increased
47,829
+44.5%
$972,0000.0%$336.80
34
2021-Q3
Decreased
33,110
-58.4%
$1M0.0%$472.80
0
2021-Q2
Increased
79,671
+12.6%
$2.3M0.0%$490.08
29
2021-Q1
Decreased
70,789
-91.3%
$3.1M0.0%$657.60
0
2020-Q4
Increased
814,242
+8.6%
$37.6M0.0%$787.52
32
2020-Q3
Increased
749,621
+138.8%
$32.5M0.0%$688.64
47
2020-Q2
New
313,962
-
$16.6M0.0%$812.16
39

Other major holders of BTAI: BNP PARIBAS FINANCIAL MARKETS, ADAGE CAPITAL PARTNERS GP, L.L.C., ALLIANCEBERNSTEIN L.P., VICTORY CAPITAL MANAGEMENT INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used